Numinus Wellness Inc (TSE:NUMI) has released an update.
Numinus Wellness Inc. is honing its operational strategies by emphasizing growth in the U.S. market, while scaling back its Canadian clinical operations to adopt a more resource-efficient, capital-light model. The company is also expanding its Psychedelic Assisted Therapy training program to equip more healthcare professionals for mental health care advancements. This refocus on the U.S., where Numinus generated the majority of its revenue in 2023, aims to enhance shareholder returns and capitalize on emerging opportunities in psychedelic therapies.
For further insights into TSE:NUMI stock, check out TipRanks’ Stock Analysis page.
